PRESS RELEASES

Press Release Release Date Download
TherapeuticsMD elects Jules A. Musing to Board of Directors 5/16/2013
TherapeuticsMD reports first quarter 2013 financial results 5/8/2013
TherapeuticsMD Announces Trading of its Common Stock on the NYSE MKT under symbol "TXMD" 4/19/2013
TherapeuticsMD Announces Pricing of Public Offering of Common Stock 3/15/2013
TherapeuticsMD Announces $50,000,000 Proposed Public Offering of Common Stock 3/7/2013
BocaGreenMD, Inc. Launches Line of Generic Prescription Prenatal Multivitamins 11/1/2012
TherapeuticsMD, Inc. Announces $8.5 Million Private Placement 9/26/2012
TherapeuticsMD, Inc. Has IND Filing Accepted By FDA 8/7/2012
TherapeuticsMD, Inc. Launches vitaMedMD™ Iron 21/7, a Unique, Patient-friendly Iron Supplement 7/17/2012
TherapeuticsMD, Inc. Announces Plans in Hormone Therapy That Concur with the Recent Joint Statement From NAMS, ASRM and the Endocrine Society 7/10/2012
TherapeuticsMD, Inc. Files for Two Additional Patents on Prescription Products For Treatment of Menopausal Symptoms & Related Conditions 6/21/2012
Tommy G. Thompson, Former U.S. Secretary of Health and Human Services, Joins TherapeuticsMD, Inc. as Chairman 5/16/2012
TherapeuticsMD, Inc. Launches VitaMedMD RediChew Rx, The First Daily Chewable Prescription Prenatal Vitamin with Quatrefolic 5/10/2012
TherapeuticsMD, Inc. Launches VitaMedMD One Rx, The First Daily One Pill Prescription Prenatal Vitamin with Quatrefolic and Plant-Based DHA 4/9/2012
TherapeuticsMD, Inc. Elects Four Additional Directors 3/2/2012
TherapeuticsMD, Inc. Launches VitaMedMD Plus Rx, The First Prescription Prenatal Vitamin with Quatrefolic and Plant-Based DHA 3/2/2012
TherapeuticsMD, Inc. Launches Its First Prescription Prenatal Vitamin on March 1, 2012 2/7/2012
TherapeuticsMD, Inc. Acquires VitaMedMD, LLC 10/5/2011
Home      |      Contact Us